NuStar GP (NYSE:NSH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Thursday.
According to Zacks, “NUSTAR GP HOLDINGS is a publicly traded limited liability company that owns the two percent general partner interest, a 18.4 percent limited partner interest and the incentive distribution rights in NuStar Energy L.P.They are one of the largest asphalt refiners and marketers and independent terminal and petroleum liquids pipeline operators in the nation with operations in the United States, Netherlands Antilles, Canada, Mexico, the Netherlands and the United Kingdom. “
Several other analysts also recently issued reports on the stock. Barclays decreased their price objective on shares of NuStar GP from $22.00 to $21.00 and set an “equal weight” rating for the company in a report on Wednesday, November 8th. ValuEngine downgraded shares of NuStar GP from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Citigroup raised shares of NuStar GP from a “neutral” rating to a “buy” rating and set a $17.00 price objective for the company in a report on Tuesday, December 5th. B. Riley started coverage on shares of NuStar GP in a report on Friday, January 26th. They set a “buy” rating and a $20.00 price objective for the company. Finally, Mizuho reaffirmed a “hold” rating and set a $21.00 price objective on shares of NuStar GP in a report on Friday, November 10th. One analyst has rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company. NuStar GP presently has an average rating of “Hold” and a consensus target price of $20.38.
NuStar GP (NYSE:NSH) last posted its quarterly earnings data on Thursday, February 8th. The pipeline company reported $0.17 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.29 by ($0.12). The firm had revenue of $10.30 million for the quarter, compared to the consensus estimate of $12.68 million. NuStar GP had a return on equity of 23.49% and a net margin of 168.31%. equities analysts predict that NuStar GP will post 1.42 EPS for the current year.
Large investors have recently added to or reduced their stakes in the stock. BNP Paribas Arbitrage SA acquired a new position in NuStar GP during the 3rd quarter valued at $103,000. Covenant Multifamily Offices LLC acquired a new position in NuStar GP during the 4th quarter valued at $131,000. Raymond James & Associates acquired a new position in NuStar GP during the 4th quarter valued at $168,000. Alliancebernstein L.P. raised its stake in NuStar GP by 5.9% during the 2nd quarter. Alliancebernstein L.P. now owns 8,841 shares of the pipeline company’s stock valued at $216,000 after purchasing an additional 495 shares during the last quarter. Finally, Brown Advisory Inc. raised its stake in NuStar GP by 70.0% during the 4th quarter. Brown Advisory Inc. now owns 17,000 shares of the pipeline company’s stock valued at $267,000 after purchasing an additional 7,000 shares during the last quarter. Hedge funds and other institutional investors own 55.53% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.tickerreport.com/banking-finance/3229627/nustar-gp-nsh-downgraded-by-zacks-investment-research-to-hold.html.
NuStar GP Company Profile
NuStar GP Holdings, LLC holds interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the transportation of petroleum products and anhydrous ammonia, the terminalling and storage of petroleum products and the marketing of petroleum products. NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NuStar GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NuStar GP and related companies with MarketBeat.com's FREE daily email newsletter.